Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Hugo Vanderstichele

1-50 of 79 results

View this query on the Wikidata Query Service
Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects

scientific article published on April 2009
Simultaneous measurement of beta-amyloid(1-42), total tau, and phosphorylated tau (Thr181) in cerebrospinal fluid by the xMAP technology

scientific article published on 24 November 2004
Diagnosis-independent Alzheimer disease biomarker signature in cognitively normal elderly people

scientific article
CSF biomarker variability in the Alzheimer's Association quality control program

scientific article published on May 2013
Measurement of phosphorylated tau epitopes in the differential diagnosis of Alzheimer disease: a comparative cerebrospinal fluid study

scientific article
The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers

scientific article published on July 2011
Qualification of the analytical and clinical performance of CSF biomarker analyses in ADNI.

scientific article
Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: a consensus paper from the Alzheimer's Biomarkers Standardization Initiative

scientific article
Evaluation of plasma Abeta(40) and Abeta(42) as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment

scientific article
Diagnostic performance of a CSF-biomarker panel in autopsy-confirmed dementia

scientific article published on 10 April 2007
CSF Aβ42/Aβ40 and Aβ42/Aβ38 ratios: better diagnostic markers of Alzheimer disease

scientific article published on January 2016
Comparison of Analytical Platforms for Cerebrospinal Fluid Measures of β-Amyloid 1-42, Total tau, and P-tau181 for Identifying Alzheimer Disease Amyloid Plaque Pathology

scientific article published on May 9, 2011
Factors affecting Aβ plasma levels and their utility as biomarkers in ADNI

scientific article published on 30 July 2011
Effects of processing and storage conditions on amyloid beta (1-42) and tau concentrations in cerebrospinal fluid: implications for use in clinical practice

scientific article published on 11 November 2004
Blood-based biomarkers in Alzheimer disease: Current state of the science and a novel collaborative paradigm for advancing from discovery to clinic

scientific article published on 18 November 2016
Cerebrospinal fluid biomarkers in trials for Alzheimer and Parkinson diseases

scientific article
Analytical performance and clinical utility of the INNOTEST PHOSPHO-TAU181P assay for discrimination between Alzheimer's disease and dementia with Lewy bodies

scientific article published in January 2006
Changes in plasma amyloid beta in a longitudinal study of aging and Alzheimer's disease

scientific article published on 13 March 2013
Intra-individual stability of CSF biomarkers for Alzheimer's disease over two years.

scientific article published in November 2007
Multiplexed quantification of dementia biomarkers in the CSF of patients with early dementias and MCI: a multicenter study

scientific article published on 19 January 2007
Alzheimer's disease cerebrospinal fluid biomarker in cognitively normal subjects

scientific article
Amino-truncated beta-amyloid42 peptides in cerebrospinal fluid and prediction of progression of mild cognitive impairment

scientific article published on 14 July 2005
Plasma levels of beta-amyloid(1-40), beta-amyloid(1-42), and total beta-amyloid remain unaffected in adult patients with hypercholesterolemia after treatment with statins

scientific article published in March 2004
CSF Aβ1-42 - an excellent but complicated Alzheimer's biomarker - a route to standardisation

scientific article
Simultaneous analysis of cerebrospinal fluid biomarkers using microsphere-based xMAP multiplex technology for early detection of Alzheimer’s disease

scientific article published on 06 April 2012
Risk of Alzheimer's Disease Biological Misdiagnosis Linked to Cerebrospinal Collection Tubes

scientific article published on 01 January 2012
Reference measurement procedures for Alzheimer's disease cerebrospinal fluid biomarkers: definitions and approaches with focus on amyloid β42.

scientific article published on August 2012
Neurofilament ELISA validation

scientific article published on 24 October 2009
Improved protocol for measurement of plasma β-amyloid in longitudinal evaluation of Alzheimer's Disease Neuroimaging Initiative study patients

scientific article published on July 2012
Cerebrospinal fluid levels of total-tau, phospho-tau and A beta 42 predicts development of Alzheimer's disease in patients with mild cognitive impairment

scientific article published on 01 January 2003
Added diagnostic value of CSF biomarkers in differential dementia diagnosis

scientific article published on 15 January 2009
The Alzheimer's Disease Neuroimaging Initiative 2 Biomarker Core: A review of progress and plans

scientific article published on July 2015
Assessing the commutability of reference material formats for the harmonization of amyloid-β measurements

article
Comparison of two analytical platforms for the clinical qualification of Alzheimer's disease biomarkers in pathologically-confirmed dementia

scientific article published in January 2013
Cerebrospinal fluid collection tubes: a critical issue for Alzheimer disease diagnosis

scientific article published on 8 February 2012
Analytical aspects of molecular Alzheimer's disease biomarkers

scientific article published on August 2012
How to handle adsorption of cerebrospinal fluid amyloid β (1-42) in laboratory practice? Identifying problematic handlings and resolving the issue by use of the Aβ42/Aβ40 ratio

scientific article published on 18 February 2017
The impact of preanalytical variables on measuring cerebrospinal fluid biomarkers for Alzheimer's disease diagnosis: A review

scientific article published on 23 June 2018
Diagnostic Impact of Cerebrospinal Fluid Biomarker (Pre-)Analytical Variability in Alzheimer's Disease

scientific article published on 19 January 2016
Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: A View of the Regulatory Science Qualification Landscape from the Coalition Against Major Diseases CSF Biomarker Team

scientific article
Validation of a multiplex assay for simultaneous quantification of amyloid-β peptide species in human plasma with utility for measurements in studies of Alzheimer's disease therapeutics

scientific article published in January 2012
Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer's disease core biomarkers in Lewy body disorders and Alzheimer's dementia

scientific article published on 28 July 2017
Prevention of tau increase in cerebrospinal fluid of APP transgenic mice suggests downstream effect of BACE1 inhibition

scientific article published on 14 October 2016
No diurnal variation of classical and candidate biomarkers of Alzheimer's disease in CSF.

scientific article published on 07 September 2016
A user's guide for α-synuclein biomarker studies in biological fluids: Perianalytical considerations

scientific article
Relation of Odor Identification with Alzheimer's Disease Markers in Cerebrospinal Fluid and Cognition

scientific article
Validation of ELISA Methods for Quantification of Total Tau and Phosphorylated-Tau181 in Human Cerebrospinal Fluid with Measurement in Specimens from Two Alzheimer's Disease Studies

scientific article published on January 1, 2011
Increased total-Tau levels in cerebrospinal fluid of pediatric hydrocephalus and brain tumor patients

scientific article published on 22 October 2007
Plasma Amyloid-β Levels, Cerebral Small Vessel Disease, and Cognition: The Rotterdam Study

scientific article published in January 2017
C-Reactive Protein, Plasma Amyloid-β Levels, and Their Interaction With Magnetic Resonance Imaging Markers

scientific article published on 01 November 2018

Paulina is supported by:

About Paulina

Help